TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-5.03%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$1.81B
AUM Growth
+$1.81B
(+20%)
Cap. Flow
+$419M
Cap. Flow
% of AUM
23.17%
Top 10 Holdings %
Top 10 Hldgs %
39.2%
Holding
208
New
25
Increased
78
Reduced
31
Closed
6
Top Buys
| 1 |
Dynavax Technologies
DVAX
|
$50.6M |
| 2 |
Galapagos
GLPG
|
$45.2M |
| 3 |
Kiniksa Pharmaceuticals
KNSA
|
$33.1M |
| 4 |
Spyre Therapeutics
SYRE
|
$33.1M |
| 5 |
SLRN
ACELYRIN
SLRN
|
$24.3M |
Top Sells
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$10.6M |
| 2 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
$7.23M |
| 3 |
GRAL
GRAIL, Inc. Common Stock
GRAL
|
$4.82M |
| 4 |
ALMS
Alumis Inc. Common Stock
ALMS
|
$4.72M |
| 5 |
Seer Inc
SEER
|
$1.52M |
Sector Composition
| 1 | Healthcare | 94.79% |
| 2 | Technology | 1.25% |
| 3 | Communication Services | 1.23% |
| 4 | Consumer Discretionary | 0.99% |
| 5 | Financials | 0.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
201
Sutro Biopharma
STRO
$85.6M
| $130K | 0.01% |
+200,000
| New | +$130K |
|
|
AFMD
202
DELISTED
Affimed
AFMD
| $107K | 0.01% |
148,315
| – | – |
|
203
Editas Medicine
EDIT
$225M
| – | – |
-400,000
| Closed | -$508K |
|
204
Immuneering
IMRX
$229M
| – | – |
-12,073
| Closed | -$26.6K |
|
205
Relmada Therapeutics
RLMD
$48.8M
| – | – |
-200,825
| Closed | -$104K |
|
|
ALMS
206
Alumis Inc. Common Stock
ALMS
$483M
| – | – |
-600,000
| Closed | -$4.72M |
|
|
OMIC
207
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| – | – |
-372,000
| Closed | -$7.23M |
|
|
MRNS
208
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| – | – |
-1,641,945
| Closed | -$879K |
|